Section of Cardiology, Center for Heart and Vascular Health, ChristianaCare Health System, Newark, Delaware, USA.
Section of Cardiology, Center for Heart and Vascular Health, ChristianaCare Health System, Newark, Delaware, USA. Email:
J Invasive Cardiol. 2024 Oct;36(10). doi: 10.25270/jic/24.00150.
The COVID-19 pandemic led to disruptions in iodinated contrast media (ICM) production and produced a global product shortage in the spring of 2022. The ACIST CVi system is an automated contrast injector system approved by the FDA for multi-patient dosing of ICM from a single container. A transition from the traditional manifold system for contrast injection to the ACIST CVi automated injector system in our cardiac angiographic labs during the COVID-19 pandemic led to reductions in contrast waste and cost while limiting patient exposure to ICM.
COVID-19 大流行导致碘造影剂（ICM）的生产中断，并在 2022 年春季导致全球产品短缺。ACIST CVi 系统是一种经 FDA 批准的自动化造影剂注射器系统，可从单个容器对多个患者进行 ICM 多剂量给药。在 COVID-19 大流行期间，我们的心脏血管造影实验室将传统的造影剂注射器系统转换为 ACIST CVi 自动化注射器系统，这减少了造影剂的浪费和成本，同时限制了患者接触 ICM 的机会。
Zotero 插件